tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lisata Therapeutics announces mutual termination of license agreement with Qilu
PremiumThe FlyLisata Therapeutics announces mutual termination of license agreement with Qilu
2M ago
Lisata Therapeutics Agrees to All-Cash Acquisition by Kuva
Premium
Company Announcements
Lisata Therapeutics Agrees to All-Cash Acquisition by Kuva
2M ago
Lisata Therapeutics downgraded to Hold from Buy at Brookline
Premium
The Fly
Lisata Therapeutics downgraded to Hold from Buy at Brookline
2M ago
Lisata Therapeutics highlights iRGD cyclic peptide product candidate data
PremiumThe FlyLisata Therapeutics highlights iRGD cyclic peptide product candidate data
5M ago
LSTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LSTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Lisata Therapeutics Highlights Cancer Therapy Innovations
Premium
Company Announcements
Lisata Therapeutics Highlights Cancer Therapy Innovations
5M ago
Lisata Therapeutics: Promising Pipeline and Strong Financials Support Buy Rating
PremiumRatingsLisata Therapeutics: Promising Pipeline and Strong Financials Support Buy Rating
7M ago
Lisata Therapeutics’ Earnings Call Highlights Strategic Growth
Premium
Company Announcements
Lisata Therapeutics’ Earnings Call Highlights Strategic Growth
7M ago
Lisata Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Lisata Therapeutics Reports Q2 2025 Financial Results
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100